Clinical trials in Petrzalka

36 clinical trials in Petrzalka, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SlovakiaKlinickeSkusky.sk

Petrzalka at a glance

clinical trials

Research sites0

Quick filters

36 trials in Petrzalka

Open in trial search

Arteriosclerosis

Recruiting

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Laroprovstat
Sponsor:AstraZeneca AB

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Registered drug

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Neovascular age-related macular degeneration

Recruiting

Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

InvestigationalNo placebo

Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

InvestigationalNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Aflibercept
Sponsor:Amgen Inc.

Contact Research Centre

Age-related macular degeneration

Recruiting

A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Registered drugNo placebo

A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Aflibercept
Sponsor:Eyebiotech Limited

Contact Research Centre

Diabetic retinal oedema

Recruiting

A study to compare the efficacy and safety of AVT29 and aflibercept in patients with diabetic macular edema

Registered drugNo placebo

A study to compare the efficacy and safety of AVT29 and aflibercept in patients with diabetic macular edema

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Aflibercept
Sponsor:Alvotech Swiss AG

Contact Research Centre

Chronic kidney disease+1

Recruiting

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational

Slovakia

Participants:18–64 years · 65+ years
Sponsor:Eli Lilly & Co.

Contact Research Centre

Neurogenic bladder

Recruiting

Study on the Safety and Effectiveness of Vibegron for Children Aged 2 to 17 with Neurogenic Bladder Overactivity Using Clean Intermittent Catheterization

InvestigationalNo placebo

Study on the Safety and Effectiveness of Vibegron for Children Aged 2 to 17 with Neurogenic Bladder Overactivity Using Clean Intermittent Catheterization

InvestigationalNo placebo

Slovakia

Participants:0–17 years
Substances:Vibegron
Sponsor:Sumitomo Pharma America Inc.

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Slovakia

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Registered drug

Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Registered drug

Slovakia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Emtricitabine
Sponsor:Novartis Pharma AG

Contact Research Centre

Obesity

Not recruiting

Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Investigational

Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Investigational

Slovakia

Participants:18–64 years · 65+ years
Sponsor:Metsera Inc.

Contact Research Centre

Obesity

Not recruiting

A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

Investigational

A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

Investigational

Slovakia

Participants:18–64 years · 65+ years
Sponsor:Metsera Inc.

Contact Research Centre

Type 2 diabetes mellitus+3

Not recruiting

A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

Registered drug

A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Cagrilintide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Petrzalka

What the registry says about research in the country

01 Cardiovascular Research

Extensive clinical trials focusing on cardiovascular diseases and preventive treatments, including studies on atherosclerosis, myocardial infarction, and stroke prevention.

Atherosclerotic cardiovascular disease treatments
Acute myocardial infarction management
Stroke prevention strategies

Novel therapies being evaluated include inclisiran and pelacarsen for reducing cardiovascular events.

02 Metabolic Disorders

Research initiatives targeting metabolic conditions, with particular emphasis on obesity, diabetes, and lipid disorders management.

Type 2 diabetes treatments
Obesity management
Hypertriglyceridemia therapies

Studies evaluating new treatments like semaglutide and specialized medications for severe metabolic disorders.

03 Autoimmune Conditions

Innovative research into autoimmune disorders, including trials for Sjögren's Syndrome, lupus, and chronic urticaria.

Systemic Lupus Erythematosus treatments
Primary Sjögren's Disease therapies
Chronic urticaria management

Testing advanced biologics and targeted therapies for autoimmune condition management.

04 Neurological Studies

Clinical research focusing on neurological disorders and mental health conditions, including schizophrenia and neurogenic conditions.

Schizophrenia treatment advances
Neurogenic detrusor overactivity
Pediatric neurological conditions

Evaluation of new therapeutic approaches for complex neurological disorders.

Back to Slovakia All countries